{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Hazelwood",
      "state": "MO",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "62696",
      "recalling_firm": "Mallinckrodt Inc",
      "address_1": "675 James S McDonnell Blvd",
      "address_2": "N/A",
      "postal_code": "63042-2301",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "FAX",
      "distribution_pattern": "AZ, CT, MO, MS, PA, FL, WA, NC, CA, TX, OK",
      "recall_number": "D-1692-2012",
      "product_description": "Thallous Chloride Tl 201 Injection, Diagnostic Sterile, Non-Pyrogenic Solution, a) 2.8 mL (NDC 0019N12028) b) 6.3ml (NDC 0019N12063) For Intravenous Administration, each milliliter contains 37 MBq (1 mCi) Thallous Chloride Tl 201 (no carrier added) at date and time of calibration, 9 mg sodium chloride and 0.9% (v/v) benzyl alcohol as a preservative, RX, Mallinckrodt Inc., St. Louis, MO 63134",
      "product_quantity": "12/2.8mCi-vials and 12/6.3mCi-vials",
      "reason_for_recall": "Labeling: Correct Labeled Product Miscart/Mispack: labels on outer containers do not match labels on vials (the correct label)",
      "recall_initiation_date": "20120730",
      "center_classification_date": "20120925",
      "termination_date": "20121116",
      "report_date": "20121003",
      "code_info": "Lot 120-2686, exp. 8/2/12.",
      "more_code_info": ""
    }
  ]
}